FDA Enlists Companies To Head Off Drug Shortages

Under the proposed rule, companies that make widely-used prescription medicines would have to notify the FDA of any changes in drug production that could disrupt the U.S. supply. FDA leaders say the advance warning will help the agency work with companies to resolve supply problems or find alternate sources of drugs that are being phased out.

WASHINGTON (AP) -- The Food and Drug Administration is announcing a new proposal designed to head off more shortages of crucial medications that have disrupted care at hospitals and health clinics nationwide.

Under the proposed rule, companies that make widely-used prescription medicines would have to notify the FDA of any changes in drug production that could disrupt the U.S. supply.

FDA leaders say the advance warning will help the agency work with companies to resolve supply problems or find alternate sources of drugs that are being phased out.

The U.S. has seen a spike in drug shortages over the past six years, particularly inexpensive generic injected drugs, including powerful antibiotics, painkillers and anesthetics used in surgery. They are the workhorses of hospitals but often produce little profit for companies.


More from MBTMag.com

Obama To Pitch The U.S. To Foreign Investors

Chrysler IPO Could Happen By Year End

Report: NSA Broke Into Data Centers

Explore more news here.

More in Supply Chain